chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: Rash chest neck to waist; Pain at injection site left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash chest neck to waist) and VACCINATION SITE PAIN (Pain at injection site left arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site left arm). On 02-May-2021, the patient experienced RASH (Rash chest neck to waist). The patient was treated with PREDNISONE at an unspecified dose and frequency. On 15-Apr-2021, VACCINATION SITE PAIN (Pain at injection site left arm) had resolved. At the time of the report, RASH (Rash chest neck to waist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed 42 day dosing window; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 42 day dosing window) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 42 day dosing window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 42 day dosing window) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment details were provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: adverse event; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (adverse event). At the time of the report, ADVERSE EVENT (adverse event) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (adverse event). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore Injection Site) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.  In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PAIN (Sore Injection Site). In March 2021, VACCINATION SITE PAIN (Sore Injection Site) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No concomitant medication was reported. Treatment medication was not provided.   This case was linked to MOD-2021-103195, MOD-2021-109892 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain in extremity, Pyrexia, Swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of swelling, pain in extremity (stabbing pain near the elbow), severe headache, arthralgia (pain in the shoulder) and pyrexia (low-grade fever) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19  vaccine) for COVID-19 immunization. No medical history provided. Concomitant products included gabapentin for an unknown indication. On Apr 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 22, 2021, patient experienced severe headache and  arthralgia (pain in the shoulder). On an unknown date, patient experienced swelling, pain in extremity (stabbing pain near the elbow) and pyrexia (low-grade fever). At the time of the report, swelling, pain in extremity (stabbing pain near the elbow), severe headache and pyrexia (low-grade fever) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. Treatment: Tylenol.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: young lady got the first vaccine last week who was under age; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (young lady got the first vaccine last week who was under age) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (young lady got the first vaccine last week who was under age). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (young lady got the first vaccine last week who was under age) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pain in extremity, Pruritus
Clinical narrative: Itching all over the body (but one certain body region everyday); Sore; Arm was red; Arm hurt a lot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body (but one certain body region everyday)), ERYTHEMA (Arm was red), PAIN IN EXTREMITY (Arm hurt a lot) and PAIN (Sore) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.No concomitant medication was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced ERYTHEMA (Arm was red) and PAIN IN EXTREMITY (Arm hurt a lot). On 09-Apr-2021, the patient experienced PRURITUS (Itching all over the body (but one certain body region everyday)) and PAIN (Sore). At the time of the report, PRURITUS (Itching all over the body (but one certain body region everyday)), ERYTHEMA (Arm was red), PAIN IN EXTREMITY (Arm hurt a lot) and PAIN (Sore) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 19-Jan-2021 and the estimated date of delivery was 24-Oct-2021. On 19-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. On 18-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. Not Provided. The patient believed she was pregnant four or five days before the date of her last menstrual cycle. Concomitant medication and treatment information were not reported.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: numbness in my arm and fingers; tingling like arm or leg fall asleep after receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in my arm and fingers) and PARAESTHESIA (tingling like arm or leg fall asleep after receiving the second dose) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 002B21A,) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DULOXETINE, CARBAMAZEPINE (TEGRETOL), BUPROPION, CLONAZEPAM (KLONOPIN) and ARIPIPRAZOLE (ABILIFY DISCMELT) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness in my arm and fingers) and PARAESTHESIA (tingling like arm or leg fall asleep after receiving the second dose). The patient was treated with BACLOFEN at a dose of 1 dosage form. At the time of the report, HYPOAESTHESIA (numbness in my arm and fingers) and PARAESTHESIA (tingling like arm or leg fall asleep after receiving the second dose) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dyspnoea, Malaise, Vaccination site pain
Clinical narrative: shortness of breath; not feeling well/  kind of off; weakness in legs for 3 weeks; low appetite; her arm was sore for a day; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), MALAISE (not feeling well/  kind of off), ASTHENIA (weakness in legs for 3 weeks), DECREASED APPETITE (low appetite) and VACCINATION SITE PAIN (her arm was sore for a day) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCODONE, DULOXETINE, METOPROLOL, CALCIUM, MENAQUINONE-7 (VITAMIN K 2), CURCUMA LONGA, PIPER NIGRUM (TURMERIC & BLACK PEPPAR), RESVERATROL, FISH OIL, ROSUVASTATIN CALCIUM (CRESTOR), MACROGOL 3350 (MIRALAX) and MAGNESIUM for an unknown indication.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (her arm was sore for a day). On an unknown date, the patient experienced DYSPNOEA (shortness of breath), MALAISE (not feeling well/  kind of off), ASTHENIA (weakness in legs for 3 weeks) and DECREASED APPETITE (low appetite). At the time of the report, DYSPNOEA (shortness of breath), MALAISE (not feeling well/  kind of off), ASTHENIA (weakness in legs for 3 weeks), DECREASED APPETITE (low appetite) and VACCINATION SITE PAIN (her arm was sore for a day) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Myalgia, Pain in extremity
Clinical narrative: left leg started throbbing; swelling of arm -feet; swollen face; dizziness; swollen head; chills - Shivers; Muscle aches; felt feverish; injection site is painful; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left leg started throbbing), PERIPHERAL SWELLING (swelling of arm -feet), SWELLING FACE (swollen face), DIZZINESS (dizziness) and SWELLING (swollen head) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced CHILLS (chills - Shivers), MYALGIA (Muscle aches), PYREXIA (felt feverish), VACCINATION SITE PAIN (injection site is painful) and FATIGUE (fatigue). On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (left leg started throbbing), PERIPHERAL SWELLING (swelling of arm -feet), SWELLING FACE (swollen face), DIZZINESS (dizziness) and SWELLING (swollen head). At the time of the report, PAIN IN EXTREMITY (left leg started throbbing), PERIPHERAL SWELLING (swelling of arm -feet), SWELLING FACE (swollen face), DIZZINESS (dizziness), SWELLING (swollen head), CHILLS (chills - Shivers), MYALGIA (Muscle aches), PYREXIA (felt feverish), VACCINATION SITE PAIN (injection site is painful) and FATIGUE (fatigue) outcome was unknown.            Concomitant details were not provided.  Treatment details were not provided.   This case was linked to MOD-2021-065338.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Swelling, Swelling face, Vaccination site pain
Clinical narrative: left leg started throbbing; swelling of arm -feet; swollen face; dizziness; swollen head; chills - Shivers; Muscle aches; felt feverish; injection site is painful; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left leg started throbbing), PERIPHERAL SWELLING (swelling of arm -feet), SWELLING FACE (swollen face), DIZZINESS (dizziness) and SWELLING (swollen head) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced CHILLS (chills - Shivers), MYALGIA (Muscle aches), PYREXIA (felt feverish), VACCINATION SITE PAIN (injection site is painful) and FATIGUE (fatigue). On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (left leg started throbbing), PERIPHERAL SWELLING (swelling of arm -feet), SWELLING FACE (swollen face), DIZZINESS (dizziness) and SWELLING (swollen head). At the time of the report, PAIN IN EXTREMITY (left leg started throbbing), PERIPHERAL SWELLING (swelling of arm -feet), SWELLING FACE (swollen face), DIZZINESS (dizziness), SWELLING (swollen head), CHILLS (chills - Shivers), MYALGIA (Muscle aches), PYREXIA (felt feverish), VACCINATION SITE PAIN (injection site is painful) and FATIGUE (fatigue) outcome was unknown.            Concomitant details were not provided.  Treatment details were not provided.   This case was linked to MOD-2021-065338.
Sex: U
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rash
Clinical narrative: Sore throat; Severe body rash; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-May-2021 and was forwarded to Moderna on 04-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat) and RASH (Severe body rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and RASH (Severe body rash). At the time of the report, OROPHARYNGEAL PAIN (Sore throat) and RASH (Severe body rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was also given steroids
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site dysaesthesia, Vaccination site pain, Vaccination site rash
Clinical narrative: sensitive at injection site; soreness at injection site; not inflamed but bumpy; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE DYSAESTHESIA (sensitive at injection site), VACCINATION SITE PAIN (soreness at injection site) and VACCINATION SITE RASH (not inflamed but bumpy) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004CZ1A and 021BZ1A) for COVID-19 vaccination.     no medical history information was reported.  Concomitant products included IBUPROFEN for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced VACCINATION SITE DYSAESTHESIA (sensitive at injection site), VACCINATION SITE PAIN (soreness at injection site) and VACCINATION SITE RASH (not inflamed but bumpy). At the time of the report, VACCINATION SITE DYSAESTHESIA (sensitive at injection site), VACCINATION SITE PAIN (soreness at injection site) and VACCINATION SITE RASH (not inflamed but bumpy) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route), the reporter did not provide any causality assessment. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable patient noted that second shot was administered after a band-aid was applied. Patient also noted he received a gel injection to the knee on 21Apr2021 but didn't know what it was. no treatment information was reported.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chest pain, Pharyngeal erythema, Rhinorrhoea
Clinical narrative: post nasal drainage; "My throat is red" said the doctor, maybe irritation; anxious; chest pain that comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxious), CHEST PAIN (chest pain that comes and goes), RHINORRHOEA (post nasal drainage) and PHARYNGEAL ERYTHEMA ("My throat is red" said the doctor, maybe irritation) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced ANXIETY (anxious) and CHEST PAIN (chest pain that comes and goes). On 23-Apr-2021, the patient experienced RHINORRHOEA (post nasal drainage) and PHARYNGEAL ERYTHEMA ("My throat is red" said the doctor, maybe irritation). The patient was treated with AMOXICILLIN (oral) at a dose of 875 mg twice a day. At the time of the report, ANXIETY (anxious), CHEST PAIN (chest pain that comes and goes), RHINORRHOEA (post nasal drainage) and PHARYNGEAL ERYTHEMA ("My throat is red" said the doctor, maybe irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Carpal tunnel syndrome, Chills, Headache, Magnetic resonance imaging, Nausea
Clinical narrative: carpal tunnel left hand; pain at injection site; headache; chills; nausea; throwing up that night; This spontaneous case was reported by a consumer and describes the occurrence of CARPAL TUNNEL SYNDROME (carpal tunnel left hand), CHILLS (chills), NAUSEA (nausea), VOMITING (throwing up that night) and VACCINATION SITE PAIN (pain at injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sarcoidosis, Asthma, Carpal tunnel syndrome and Rotator cuff tear. Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and VITAMINS NOS for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced CHILLS (chills), NAUSEA (nausea) and VOMITING (throwing up that night). On an unknown date, the patient experienced CARPAL TUNNEL SYNDROME (carpal tunnel left hand), VACCINATION SITE PAIN (pain at injection site) and HEADACHE (headache). At the time of the report, CARPAL TUNNEL SYNDROME (carpal tunnel left hand), CHILLS (chills), NAUSEA (nausea) and VOMITING (throwing up that night) outcome was unknown and VACCINATION SITE PAIN (pain at injection site) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: abnormal (abnormal) Torn rotator cuff..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Followup received and contains information lab data MRI, reporter causality as not related.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: carpal tunnel left hand; pain at injection site; headache; chills; nausea; throwing up that night; This spontaneous case was reported by a consumer and describes the occurrence of CARPAL TUNNEL SYNDROME (carpal tunnel left hand), CHILLS (chills), NAUSEA (nausea), VOMITING (throwing up that night) and VACCINATION SITE PAIN (pain at injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sarcoidosis, Asthma, Carpal tunnel syndrome and Rotator cuff tear. Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and VITAMINS NOS for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced CHILLS (chills), NAUSEA (nausea) and VOMITING (throwing up that night). On an unknown date, the patient experienced CARPAL TUNNEL SYNDROME (carpal tunnel left hand), VACCINATION SITE PAIN (pain at injection site) and HEADACHE (headache). At the time of the report, CARPAL TUNNEL SYNDROME (carpal tunnel left hand), CHILLS (chills), NAUSEA (nausea) and VOMITING (throwing up that night) outcome was unknown and VACCINATION SITE PAIN (pain at injection site) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: abnormal (abnormal) Torn rotator cuff..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Followup received and contains information lab data MRI, reporter causality as not related.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm pain and arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain and arm soreness) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm pain and arm soreness). At the time of the report, PAIN IN EXTREMITY (Arm pain and arm soreness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication list was not provided. Treatment information was not provided.    This case was linked to MOD-2021-103358 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up received on 04-Jun-2021 and does not contain any new information.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: experienced a wave that started at her head and moved downward; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (experienced a wave that started at her head and moved downward) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0401321A) for COVID-19 vaccination.     The patient's past medical history included Panic attack.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced VERTIGO (experienced a wave that started at her head and moved downward). At the time of the report, VERTIGO (experienced a wave that started at her head and moved downward) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth, Rash
Clinical narrative: developed rashes, looked like "ring worm" rashes; dryness of mouth; This spontaneous case was reported by a consumer and describes the occurrence of RASH (developed rashes, looked like "ring worm" rashes) and DRY MOUTH (dryness of mouth) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (developed rashes, looked like "ring worm" rashes) and DRY MOUTH (dryness of mouth). At the time of the report, RASH (developed rashes, looked like "ring worm" rashes) and DRY MOUTH (dryness of mouth) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-103423, MOD21-086119, US-MODERNATX, INC.-MOD-2021-103531 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103423: MOD21-086119: US-MODERNATX, INC.-MOD-2021-103531:
Sex: F
Vaccine: COVID19
Symptoms: Illness, Product dose omission issue
Clinical narrative: patient was sick and missed dose appointment; sick; Patient has only received first dose on 23Mar2021, has not received second dose.; This spontaneous case was reported by a non-health professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient was sick and missed dose appointment), PRODUCT DOSE OMISSION ISSUE (Patient has only received first dose on 23Mar2021, has not received second dose.) and ILLNESS (sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has only received first dose on 23Mar2021, has not received second dose.). On 20-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient was sick and missed dose appointment) and ILLNESS (sick). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient was sick and missed dose appointment), PRODUCT DOSE OMISSION ISSUE (Patient has only received first dose on 23Mar2021, has not received second dose.) and ILLNESS (sick) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment medications were not reported  no concomitant medications were reported  for mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain in extremity, Vaccination site pain
Clinical narrative: Soreness in arm where injection was given; Right arm was stiff only when he moves it or puts pressure on it; Soreness at injection site area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm where injection was given), MUSCULOSKELETAL STIFFNESS (Right arm was stiff only when he moves it or puts pressure on it) and VACCINATION SITE PAIN (Soreness at injection site area) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in arm where injection was given), MUSCULOSKELETAL STIFFNESS (Right arm was stiff only when he moves it or puts pressure on it) and VACCINATION SITE PAIN (Soreness at injection site area). At the time of the report, PAIN IN EXTREMITY (Soreness in arm where injection was given), MUSCULOSKELETAL STIFFNESS (Right arm was stiff only when he moves it or puts pressure on it) and VACCINATION SITE PAIN (Soreness at injection site area) outcome was unknown.            Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache, Myalgia
Clinical narrative: Covered their throats, they lose their breath; Dizzy; Body aches; Headahe; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Covered their throats, they lose their breath), DIZZINESS (Dizzy), MYALGIA (Body aches) and HEADACHE (Headahe) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004c214) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced DYSPNOEA (Covered their throats, they lose their breath), DIZZINESS (Dizzy), MYALGIA (Body aches) and HEADACHE (Headahe). The patient was treated with PARACETAMOL, PHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE (THERAFLU [PARACETAMOL;PHENIRAMINE MALEATE;PHENYLEPHRINE HYDROCHLORIDE]) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ASCORBIC ACID (VITAMINE C) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Covered their throats, they lose their breath), DIZZINESS (Dizzy), MYALGIA (Body aches) and HEADACHE (Headahe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.   This case was linked to MOD-2021-103027 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Feeling abnormal, Pallor, Pyrexia
Clinical narrative: burning hot at 1 AM; looks awful; Pale; bad fever; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning hot at 1 AM), FEELING ABNORMAL (looks awful), PALLOR (Pale) and PYREXIA (bad fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced BURNING SENSATION (burning hot at 1 AM), FEELING ABNORMAL (looks awful), PALLOR (Pale) and PYREXIA (bad fever). At the time of the report, BURNING SENSATION (burning hot at 1 AM), FEELING ABNORMAL (looks awful), PALLOR (Pale) and PYREXIA (bad fever) outcome was unknown. Not Provided          Concomitant product use was not provided.  Treatment information was not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in arm especially when moving; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm especially when moving) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm especially when moving). At the time of the report, PAIN IN EXTREMITY (Soreness in arm especially when moving) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.   This case was linked to MOD-2021-103372 (E2B Linked Report).; Sender's Comments:  MOD-2021-103372:same patient, 2nd dose
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Nausea, Product dose omission issue, Vomiting
Clinical narrative: Flu like side effects every 4 days interval; Headache; Nausea; feel like vomit if she didn't lie down; Didn't take second dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like side effects every 4 days interval), HEADACHE (Headache), NAUSEA (Nausea), VOMITING (feel like vomit if she didn't lie down) and PRODUCT DOSE OMISSION ISSUE (Didn't take second dose) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like side effects every 4 days interval), HEADACHE (Headache), NAUSEA (Nausea), VOMITING (feel like vomit if she didn't lie down) and PRODUCT DOSE OMISSION ISSUE (Didn't take second dose). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like side effects every 4 days interval), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (feel like vomit if she didn't lie down) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Didn't take second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was scheduled for her second dose on 31-MAR-2021 but at vaccination site they postponed her dose schedule to 12-APR-2021 or 13-APR-2021. No concomitant medications were provided. No treatment drugs were reported.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Pyrexia, Swelling, Tendonitis
Clinical narrative: makes her arm feel like she has tendonitis; red lump was swollen; red lump that was lower than the injection site; red lump was itchy at times; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of TENDONITIS (makes her arm feel like she has tendonitis), SWELLING (red lump was swollen), VACCINATION SITE MASS (red lump that was lower than the injection site), PRURITUS (red lump was itchy at times) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced TENDONITIS (makes her arm feel like she has tendonitis), SWELLING (red lump was swollen), VACCINATION SITE MASS (red lump that was lower than the injection site), PRURITUS (red lump was itchy at times), PYREXIA (fever) and HEADACHE (headache). At the time of the report, TENDONITIS (makes her arm feel like she has tendonitis), SWELLING (red lump was swollen), VACCINATION SITE MASS (red lump that was lower than the injection site), PRURITUS (red lump was itchy at times), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-103322 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: makes her arm feel like she has tendonitis; red lump was swollen; red lump that was lower than the injection site; red lump was itchy at times; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of TENDONITIS (makes her arm feel like she has tendonitis), SWELLING (red lump was swollen), VACCINATION SITE MASS (red lump that was lower than the injection site), PRURITUS (red lump was itchy at times) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced TENDONITIS (makes her arm feel like she has tendonitis), SWELLING (red lump was swollen), VACCINATION SITE MASS (red lump that was lower than the injection site), PRURITUS (red lump was itchy at times), PYREXIA (fever) and HEADACHE (headache). At the time of the report, TENDONITIS (makes her arm feel like she has tendonitis), SWELLING (red lump was swollen), VACCINATION SITE MASS (red lump that was lower than the injection site), PRURITUS (red lump was itchy at times), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-103322 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Oropharyngeal pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Worsening Asthma; Sore throat; Injection site itches; rash was at the injection site and on her forearms/ Bilateral raised itchy rash on my forearms; This spontaneous case was reported by an other health care professional and describes the occurrence of ASTHMA (Worsening Asthma), OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE PRURITUS (Injection site itches) and VACCINATION SITE RASH (rash was at the injection site and on her forearms/ Bilateral raised itchy rash on my forearms) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Smoker. Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL SULFATE (VENTOLIN ACCUHALER) and ALBUTEROL SULFATE for Asthma, FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA), PREDNISONE, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-May-2021, the patient experienced ASTHMA (Worsening Asthma), OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE PRURITUS (Injection site itches) and VACCINATION SITE RASH (rash was at the injection site and on her forearms/ Bilateral raised itchy rash on my forearms). At the time of the report, ASTHMA (Worsening Asthma), OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE PRURITUS (Injection site itches) and VACCINATION SITE RASH (rash was at the injection site and on her forearms/ Bilateral raised itchy rash on my forearms) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant included Claritin. No treatment was provided. Action taken with Moderna covid-19 vaccine was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: No specific follow-up information recorded.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol increased, Blood glucose increased
Clinical narrative: High Blood Sugar; High Blood Cholesterol; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (High Blood Sugar) and BLOOD CHOLESTEROL INCREASED (High Blood Cholesterol) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced BLOOD GLUCOSE INCREASED (High Blood Sugar) and BLOOD CHOLESTEROL INCREASED (High Blood Cholesterol). At the time of the report, BLOOD GLUCOSE INCREASED (High Blood Sugar) and BLOOD CHOLESTEROL INCREASED (High Blood Cholesterol) outcome was unknown. Not Provided          Relevant concomitant medications were not reported.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-103695 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103695:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling
Clinical narrative: Ankle Swelling; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Ankle Swelling) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 031B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced JOINT SWELLING (Ankle Swelling). At the time of the report, JOINT SWELLING (Ankle Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment product details not provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Confusional state
Clinical narrative: lost memory for half an hour; feel confused; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (lost memory for half an hour) and CONFUSIONAL STATE (feel confused) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced AMNESIA (lost memory for half an hour) and CONFUSIONAL STATE (feel confused). At the time of the report, AMNESIA (lost memory for half an hour) and CONFUSIONAL STATE (feel confused) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient took blood pressure, cholesterol and thyroid pills. No treatment details were provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain
Clinical narrative: feel their body is unwell; feels a lot of pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel their body is unwell) and PAIN (feels a lot of pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced MALAISE (feel their body is unwell) and PAIN (feels a lot of pain). At the time of the report, MALAISE (feel their body is unwell) and PAIN (feels a lot of pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.